On March 30th (Monday), GAIA-BT and EDGENE, a biotech developing therapeutics for mitochondrial genetic disorders, signed an MOU for joint R&D collaboration.
Partnership
GAIA-BT Signs MOU with EDGENE for Joint R&D
30 MAR 2026GAIA-BT
30 MAR 2026GAIA-BT
On March 30th (Monday), GAIA-BT and EDGENE, a biotech developing therapeutics for mitochondrial genetic disorders, signed an MOU for joint R&D collaboration.